Masimo's Stork Baby-Monitoring System Gets FDA Approval
18 Diciembre 2023 - 12:28PM
Noticias Dow Jones
By Ben Glickman
Masimo's baby-monitoring system Stork has received approval from
the U.S. Food and Drug Administration for medical uses.
The system is cleared by the FDA for prescription use in healthy
and sick babies up to 18 months old.
Stork allows parents to monitor babies' oxygen saturation, pulse
rate and skin temperature. Users can receive alarms regarding these
metrics and can share information with doctors remotely.
The Irvine, Calif.-based medical-device company said Monday that
the system was available at retailers nationwide as a non-medical
device and could now be used as a medical device with a
prescription.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
December 18, 2023 13:13 ET (18:13 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Masimo (NASDAQ:MASI)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Masimo (NASDAQ:MASI)
Gráfica de Acción Histórica
De May 2023 a May 2024